FDA Approves Hybrid Closed-Loop Insulin Delivery App from CamDiab

CamDiab announced that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX, an Android app, received approval as an interoperable automated glycemic controller device. It helps to manage glucose levels in people with type 1 diabetes, aged two and older, including during pregnancy.
[CamDiab (Drug Delivery Business)]
Press Release